Recombinant Anti-Human IGF-IR Antibody (Fc glycosylation) (CAT#: Gly-048LC)

This product is a human monoclonal antibody with N-glycosylation site Asn297 in the Fc region. The antibody with enhanced ADCC specifically binds human IGF-IR and can be potentially used in the treatment of diabete.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Datasheet
  • MSDS
  • COA

Glyco-engineering

  • Glycosylation site
  • Asn297 in Fc region
  • Glycoform (ratio)
  • G0 (44.3%)
    G1 (47.6%)
    G2 (8.1%)
  • Glycosylation Type
  • N-glycosylation
  • Activity
  • Enhanced ADCC

Specifications

  • Target
  • IGF-IR (Insulin-like growth factor-binding protein)
  • Host Species
  • Human
  • Type
  • Human antibody
  • Specificity
  • Human
  • Clone
  • Clone 2
  • Applications
  • ELISA

Target

  • Alternative Names
  • IGF-IR; Insulin-like growth factor-binding protein
  • Related Disease
  • Diabete

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "IGF-IR"

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for Gly-048LC. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare